BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33789921)

  • 1. Liver involvement in patients with coeliac disease: proof of causality using IgA/anti-TG2 colocalisation techniques.
    Dutta R; Iqbal A; Das P; Palanichamy JK; Singh A; Mehtab W; Chauhan A; Aggarwal A; Sreenivas V; Ahuja V; Datta Gupta S; Makharia GK
    J Clin Pathol; 2021 Dec; 74(12):766-773. PubMed ID: 33789921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.
    Tosco A; Aitoro R; Auricchio R; Ponticelli D; Miele E; Paparo F; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2013 Jan; 171(1):69-75. PubMed ID: 23199325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
    Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
    Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
    Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
    BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
    Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T
    Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study.
    Borrelli M; Maglio M; Korponay-Szabó IR; Vass V; Mearin ML; Meijer C; Niv-Drori H; Ribes-Koninckx C; Roca M; Shamir R; Troncone R; Auricchio R
    Clin Exp Immunol; 2018 Mar; 191(3):311-317. PubMed ID: 29114847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical Expression of Antitissue Transglutaminase 2 in Tissue Injuries: An Interpretation Beyond Celiac Disease.
    Das P; Rawat R; Verma AK; Singh G; Vallonthaiel AG; Yadav R; Gahlot GPS; Dinda AK; Ahuja V; Datta Gupta S; Agarwal SK; Makharia GK
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):425-430. PubMed ID: 27753658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
    Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?
    Lo Iacono O; Petta S; Venezia G; Di Marco V; Tarantino G; Barbaria F; Mineo C; De Lisi S; Almasio PL; Craxì A
    Am J Gastroenterol; 2005 Nov; 100(11):2472-7. PubMed ID: 16279902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy.
    Nurmi R; Korponay-Szabó I; Laurila K; Huhtala H; Niemelä O; Mustonen J; Mäkelä S; Kaukinen K; Lindfors K
    Nutrients; 2021 May; 13(5):. PubMed ID: 34064541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coeliac disease and the liver: spectrum of liver histology, serology and treatment response at a tertiary referral centre.
    Majumdar K; Sakhuja P; Puri AS; Gaur K; Haider A; Gondal R
    J Clin Pathol; 2018 May; 71(5):412-419. PubMed ID: 28970297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of celiac disease associated IgA nephropathy by IgA anti-tissue transglutaminase2 antibody deposits in archived formalin-fixed tissues.
    Dutta R; Rawat R; Das P; Singh G; Kumari A; Ahmad M; Chauhan A; Ahuja V; Agrawal SK; Makharia GK
    Saudi J Gastroenterol; 2023; 29(1):59-65. PubMed ID: 36348611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients.
    Vorobjova T; Uibo O; Heilman K; Uibo R
    World J Gastroenterol; 2015 Jan; 21(2):439-52. PubMed ID: 25593459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.
    Korponay-Szabó IR; Halttunen T; Szalai Z; Laurila K; Király R; Kovács JB; Fésüs L; Mäki M
    Gut; 2004 May; 53(5):641-8. PubMed ID: 15082580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
    Koskinen O; Villanen M; Korponay-Szabo I; Lindfors K; Mäki M; Kaukinen K
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
    Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
    Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
    Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
    Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
    Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease.
    Singh P; Kurray L; Agnihotri A; Das P; Verma AK; Sreenivas V; Dattagupta S; Makharia GK
    J Clin Gastroenterol; 2015 Mar; 49(3):212-7. PubMed ID: 24583754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-Gastrointestinal Tract Mucosal Pathologies in Patients with Celiac Disease with the Demonstration of IgA Anti-Transglutaminase Mucosal Deposits: A Case-Control Study.
    Chauhan A; Das P; Singh A; Dutta R; Rajeshwari M; Rajput MS; Agarwal A; Banyal V; Upadhay A; Ahuja V; Makharia G
    Dig Dis Sci; 2022 Aug; 67(8):3649-3661. PubMed ID: 34499270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.